Surgical Innovations Group
Plc
("Surgical Innovations", the
"Company", or the "Group")
Result of Annual General
Meeting
Surgical Innovations Group Plc (AIM:
SUN), the designer, manufacturer and distributor of innovative
technology for minimally invasive surgery, announces that all resolutions proposed at the Annual General
Meeting held earlier today were duly
passed.
The voting results will be made
available on the Meetings and Voting section of Company's website
shortly: https://www.sigroupplc.com/meetings-and-voting.
For further information please
contact:
|
Surgical Innovations Group
plc
|
www sigroupplc
com
|
|
David Marsh, CEO
Chris
Martin, CFO
|
Tel: 0113
230 7597
|
|
|
|
|
Singer
Capital Markets (Nominated Adviser & Broker)
|
Tel: 020
7496 3000
|
|
Aubrey Powell / Oliver
Platts
|
|
|
|
|
|
Walbrook PR (Financial PR &
Investor Relations)
|
Tel: 020
7933 8780 or si@walbrookpr.com
|
|
Paul McManus / Charlotte
Edgar
|
Mob: 07980
541 893 / 07884 664 686
|
|
|
|
| |
About Surgical Innovations Group
plc
The Group specialises in the design,
manufacture, sale and distribution of innovative, high quality
medical products, primarily for use in minimally invasive surgery.
Our product and business development is guided and supported by a
key group of nationally and internationally renowned surgeons
across the spectrum of minimally invasive surgical
activity.
We design and manufacture and source
our branded port access systems, surgical instruments and
retraction devices which are sold directly in the UK home market
through our subsidiary, Elemental Healthcare, and exported widely
through a global network of trusted distribution partners. Many of
our products in this field are based on a "resposable" concept, in
which the products are part reusable, part disposable, offering a
high quality and environmentally responsible solution at a cost
that is competitive against fully disposable
alternatives.
Elemental also has exclusive UK
distribution for a select portfolio of specialist products employed
in laparoscopy, bariatric and metabolic surgery, hernia repair and
breast reconstruction.
In addition, we design and develop
medical devices for carefully selected OEM partners and have also
collaborated with a major UK industrial partner to provide
precision engineering solutions to complex problems outside the
medical arena.
We aim for our brands to be
recognised and respected by healthcare professionals in all major
geographical markets in which we operate and provide by
development, partnership or acquisition a broad portfolio of cost
effective, procedure specific surgical instruments and implantable
devices that offer reliable solutions to genuine clinical needs in
the operating theatre environment.
Further information
Further details of the Group's
businesses and products are available on the following
websites:
www.sigroupplc.com
www.surginno.com
www.elementalhealthcare.co.uk
To receive regular updates by email,
please contact si@walbrookpr.com